NCT04080882View on ClinicalTrials.gov

Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Platysmal Bands

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 25, 2019

Primary Completion Date

December 30, 2019

Study Completion Date

June 4, 2020

Conditions
Platysmal Bands
Interventions
BIOLOGICAL

AbobotulinumtoxinA dose 1

Treatment of platysmal bands

OTHER

Placebo

Treatment of platysmal bands

BIOLOGICAL

AbobotulinumtoxinA dose 2

Treatment of platysmal bands

BIOLOGICAL

AbobotulinumtoxinA dose 3

Treatment of platysmal bands

Trial Locations (8)

10028

Galderma Research Site, New York

21208

Galderma Research Site, Baltimore

33137

Galderma Research Site, Miami

33472

Galderma Research Site, Boynton Beach

70115

Galderma Research Site, New Orleans

70130

Galderma Research Site, New Orleans

91436

Galderma Research Site, Encino

92024

Galderma Research Site, Encinitas

Sponsors

Lead Sponsor

Galderma R&D
All Listed Sponsors
lead

Galderma R&D

INDUSTRY

NCT04080882 - Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Platysmal Bands | Biotech Hunter | Biotech Hunter